Loading...
•
Dec 31, 2023
BioNano Q4 2023 Earnings Report
Reported a 30% revenue increase compared to Q4 2022, driven by growth in OGM installed base and consumables sales.
Key Takeaways
Bionano Genomics reported a 30% increase in Q4 2023 revenue compared to Q4 2022, reaching $10.7 million. The company's ELEVATE strategy is working, with progress in OGM installed base and consumables unit sales.
Q4 2023 revenue increased by 30% year-over-year, reaching $10.7 million.
Full year 2023 revenue increased by 30% year-over-year, reaching $36.1 million.
Installed base of OGM systems increased by 36% year-over-year, totaling 326 systems at year-end 2023.
Flowcells sales increased by 67% year-over-year in Q4 2023.
Revenue by Segment
Forward Guidance
Bionano expects full year 2024 revenue to be in the range of $37.0 to $41.0 million and Q1 2024 revenue is expected to be in the range of $8.25 to $8.75 million.
Positive Outlook
- Focus on addressing cash burn and financial discipline.
- Actions to improve margins and further extend cash runway.
- Cost savings initiatives are expected to have a positive impact on operating expenses.
- Anticipate installation of 80 to 100 new OGM systems in 2024, with a projected 2024 installed base range of 381 to 401 OGM systems.
- Recently amended the convertible debt financing entered into in October 2023 to restructure our debt obligations
Challenges Ahead
- Phasing out First Step and Next Step Dx clinical services products and our Fragile X test, which are legacy, non-OGM tests.
- Potential reduction in headcount by an additional 110 to 125 employees.
- Exploring strategic opportunities that could include debt financing, equity investments, combinations with other companies, or the sale of all or part of the company.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...